| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 1.27e-06 | 2 | 23 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 4.83e-05 | 62 | 23 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | serotonin binding | 9.82e-05 | 13 | 23 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | amine binding | 2.63e-04 | 21 | 23 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 2.89e-04 | 22 | 23 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.89e-04 | 22 | 23 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.91e-04 | 884 | 23 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 6.96e-04 | 34 | 23 | 2 | GO:0016628 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.01e-03 | 41 | 23 | 2 | GO:0008227 | |
| GeneOntologyMolecularFunction | NADP binding | 2.30e-03 | 62 | 23 | 2 | GO:0050661 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 3.55e-03 | 1353 | 23 | 6 | GO:0004888 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.87e-03 | 100 | 23 | 2 | GO:0030594 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 2.49e-05 | 7 | 23 | 2 | GO:0007198 | |
| GeneOntologyBiologicalProcess | dolichol-linked oligosaccharide biosynthetic process | 2.71e-04 | 22 | 23 | 2 | GO:0006488 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.97e-04 | 23 | 23 | 2 | GO:0098664 | |
| GeneOntologyBiologicalProcess | dolichol metabolic process | 3.23e-04 | 24 | 23 | 2 | GO:0019348 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 4.74e-04 | 29 | 23 | 2 | GO:0016093 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 9.04e-04 | 40 | 23 | 2 | GO:0060117 | |
| GeneOntologyBiologicalProcess | sensory perception | 9.14e-04 | 1072 | 23 | 6 | GO:0007600 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.03e-03 | 412 | 23 | 4 | GO:0006066 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.34e-03 | 198 | 23 | 3 | GO:0007605 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 2.09e-03 | 61 | 23 | 2 | GO:0007187 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.27e-03 | 238 | 23 | 3 | GO:0050954 | |
| GeneOntologyBiologicalProcess | secondary alcohol biosynthetic process | 2.37e-03 | 65 | 23 | 2 | GO:1902653 | |
| GeneOntologyBiologicalProcess | cholesterol biosynthetic process | 2.37e-03 | 65 | 23 | 2 | GO:0006695 | |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 2.52e-03 | 67 | 23 | 2 | GO:0042491 | |
| GeneOntologyBiologicalProcess | sterol biosynthetic process | 2.90e-03 | 72 | 23 | 2 | GO:0016126 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.98e-03 | 73 | 23 | 2 | GO:0060119 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 3.22e-03 | 76 | 23 | 2 | GO:0006487 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 3.39e-03 | 78 | 23 | 2 | GO:0035315 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 3.52e-03 | 1395 | 23 | 6 | GO:0007186 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 4.11e-03 | 86 | 23 | 2 | GO:0007193 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 5.09e-03 | 96 | 23 | 2 | GO:0060113 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 5.11e-03 | 641 | 23 | 4 | GO:1901615 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TM7SF2 JKAMP WFS1 AADAC SLC33A1 PIEZO1 DHCR7 ALG10B ALG10 UBIAD1 TMEM68 | 3.29e-08 | 1293 | 23 | 11 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TM7SF2 JKAMP WFS1 AADAC SLC33A1 PIEZO1 DHCR7 ALG10B ALG10 UBIAD1 TMEM68 | 3.45e-08 | 1299 | 23 | 11 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TM7SF2 JKAMP WFS1 AADAC SLC33A1 PIEZO1 DHCR7 ALG10B ALG10 UBIAD1 TMEM68 | 4.30e-08 | 1327 | 23 | 11 | GO:0042175 |
| MousePheno | absent distortion product otoacoustic emissions | 1.55e-05 | 41 | 17 | 3 | MP:0004737 | |
| MousePheno | absent cochlear microphonics | 6.23e-05 | 10 | 17 | 2 | MP:0004413 | |
| MousePheno | bleb | 1.08e-04 | 13 | 17 | 2 | MP:0008854 | |
| MousePheno | abnormal distortion product otoacoustic emission | 1.39e-04 | 85 | 17 | 3 | MP:0004736 | |
| MousePheno | abnormal otoacoustic response | 1.44e-04 | 86 | 17 | 3 | MP:0006336 | |
| MousePheno | cochlear outer hair cell degeneration | 1.44e-04 | 86 | 17 | 3 | MP:0004404 | |
| MousePheno | abnormal limb bud morphology | 1.70e-04 | 91 | 17 | 3 | MP:0005650 | |
| MousePheno | abnormal cochlear microphonics | 2.11e-04 | 18 | 17 | 2 | MP:0004412 | |
| MousePheno | abnormal cochlear potential | 2.35e-04 | 19 | 17 | 2 | MP:0006332 | |
| MousePheno | cochlear hair cell degeneration | 2.67e-04 | 106 | 17 | 3 | MP:0004362 | |
| MousePheno | pale yolk sac | 2.97e-04 | 110 | 17 | 3 | MP:0001722 | |
| MousePheno | deafness | 3.48e-04 | 116 | 17 | 3 | MP:0001967 | |
| MousePheno | abnormal cochlear outer hair cell physiology | 5.16e-04 | 28 | 17 | 2 | MP:0004434 | |
| MousePheno | abnormal limb development | 6.03e-04 | 140 | 17 | 3 | MP:0006279 | |
| MousePheno | decreased cochlear outer hair cell number | 8.09e-04 | 35 | 17 | 2 | MP:0004402 | |
| MousePheno | abnormal otic vesicle morphology | 8.56e-04 | 36 | 17 | 2 | MP:0009806 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 8.73e-04 | 159 | 17 | 3 | MP:0004399 | |
| MousePheno | abnormal touch/ nociception | 9.28e-04 | 376 | 17 | 4 | MP:0001968 | |
| MousePheno | abnormal cochlear hair cell physiology | 1.06e-03 | 40 | 17 | 2 | MP:0004432 | |
| MousePheno | neuron degeneration | 1.07e-03 | 391 | 17 | 4 | MP:0003224 | |
| MousePheno | increased body temperature | 1.28e-03 | 44 | 17 | 2 | MP:0005533 | |
| MousePheno | abnormal optic vesicle formation | 1.46e-03 | 47 | 17 | 2 | MP:0003425 | |
| MousePheno | abnormal hair cell physiology | 1.58e-03 | 49 | 17 | 2 | MP:0003879 | |
| MousePheno | abnormal cochlear outer hair cell number | 1.65e-03 | 50 | 17 | 2 | MP:0004400 | |
| MousePheno | embryonic growth retardation | 1.71e-03 | 763 | 17 | 5 | MP:0003984 | |
| MousePheno | increased circulating glucocorticoid level | 1.71e-03 | 51 | 17 | 2 | MP:0003367 | |
| MousePheno | increased circulating corticosterone level | 1.71e-03 | 51 | 17 | 2 | MP:0001745 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.74e-03 | 202 | 17 | 3 | MP:0002622 | |
| MousePheno | decreased cochlear hair cell number | 1.85e-03 | 53 | 17 | 2 | MP:0004408 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.87e-03 | 207 | 17 | 3 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 1.92e-03 | 209 | 17 | 3 | MP:0000042 | |
| MousePheno | abnormal somite shape | 1.99e-03 | 55 | 17 | 2 | MP:0001691 | |
| MousePheno | abnormal hair cell morphology | 2.05e-03 | 214 | 17 | 3 | MP:0000045 | |
| MousePheno | neurodegeneration | 2.09e-03 | 468 | 17 | 4 | MP:0002229 | |
| MousePheno | impaired hearing | 2.31e-03 | 223 | 17 | 3 | MP:0006325 | |
| MousePheno | abnormal pericardium morphology | 2.37e-03 | 225 | 17 | 3 | MP:0000288 | |
| MousePheno | abnormal midbrain development | 2.44e-03 | 61 | 17 | 2 | MP:0003864 | |
| MousePheno | abnormal mechanoreceptor morphology | 2.55e-03 | 231 | 17 | 3 | MP:0000972 | |
| MousePheno | abnormal vitelline vasculature morphology | 2.68e-03 | 235 | 17 | 3 | MP:0003229 | |
| MousePheno | abnormal cochlear labyrinth morphology | 2.68e-03 | 235 | 17 | 3 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 2.68e-03 | 235 | 17 | 3 | MP:0003169 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 2.71e-03 | 236 | 17 | 3 | MP:0011967 | |
| MousePheno | abnormal visceral yolk sac morphology | 2.71e-03 | 236 | 17 | 3 | MP:0001718 | |
| MousePheno | abnormal vocalization | 2.74e-03 | 237 | 17 | 3 | MP:0001529 | |
| MousePheno | abnormal ear development | 2.77e-03 | 65 | 17 | 2 | MP:0003938 | |
| MousePheno | abnormal cochlear hair cell number | 3.02e-03 | 68 | 17 | 2 | MP:0004406 | |
| MousePheno | prenatal growth retardation | 3.03e-03 | 869 | 17 | 5 | MP:0010865 | |
| MousePheno | abnormal urinary bladder morphology | 3.09e-03 | 247 | 17 | 3 | MP:0000538 | |
| MousePheno | abnormal cochlea morphology | 3.12e-03 | 248 | 17 | 3 | MP:0000031 | |
| MousePheno | abnormal embryonic growth/weight/body size | 3.15e-03 | 1295 | 17 | 6 | MP:0002088 | |
| MousePheno | abnormal sensory neuron physiology | 3.38e-03 | 72 | 17 | 2 | MP:0010055 | |
| MousePheno | abnormal membranous labyrinth morphology | 3.64e-03 | 262 | 17 | 3 | MP:0000035 | |
| Domain | Alg10 | 1.45e-06 | 2 | 23 | 2 | IPR016900 | |
| Domain | 5HT1F_rcpt | 1.45e-06 | 2 | 23 | 2 | IPR000450 | |
| Domain | DIE2_ALG10 | 1.45e-06 | 2 | 23 | 2 | PF04922 | |
| Domain | Ergosterol_biosynth_ERG4_ERG24 | 4.35e-06 | 3 | 23 | 2 | IPR001171 | |
| Domain | STEROL_REDUCT_2 | 4.35e-06 | 3 | 23 | 2 | PS01018 | |
| Domain | STEROL_REDUCT_1 | 4.35e-06 | 3 | 23 | 2 | PS01017 | |
| Domain | ERG4_ERG24 | 4.35e-06 | 3 | 23 | 2 | PF01222 | |
| Domain | Sterol_reductase_CS | 4.35e-06 | 3 | 23 | 2 | IPR018083 | |
| Domain | 5HT_rcpt | 5.19e-05 | 9 | 23 | 2 | IPR002231 | |
| Domain | GPCR_Rhodpsn_7TM | 1.25e-04 | 670 | 23 | 6 | IPR017452 | |
| Domain | 7tm_1 | 1.32e-04 | 677 | 23 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.41e-04 | 685 | 23 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.48e-04 | 691 | 23 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.49e-04 | 692 | 23 | 6 | IPR000276 | |
| Domain | 7TM_GPCR_Srsx | 3.41e-04 | 112 | 23 | 3 | SM01381 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.93e-05 | 260 | 19 | 5 | M39397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 9.40e-05 | 11 | 19 | 2 | M47614 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.13e-04 | 12 | 19 | 2 | M6034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS | 1.33e-04 | 13 | 19 | 2 | M47945 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 2.31e-04 | 17 | 19 | 2 | M5872 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 5.92e-04 | 27 | 19 | 2 | MM14735 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 5.92e-04 | 27 | 19 | 2 | M16227 | |
| Pathway | WP_MONOAMINE_GPCRS | 8.86e-04 | 33 | 19 | 2 | M39585 | |
| Pathway | WP_ENTEROCYTE_CHOLESTEROL_METABOLISM | 1.06e-03 | 36 | 19 | 2 | M48067 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.11e-03 | 37 | 19 | 2 | M42558 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.43e-03 | 42 | 19 | 2 | M5868 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 1.43e-03 | 42 | 19 | 2 | M27172 | |
| Pathway | KEGG_N_GLYCAN_BIOSYNTHESIS | 1.72e-03 | 46 | 19 | 2 | M11079 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 1.79e-03 | 47 | 19 | 2 | M39853 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 2.19e-03 | 52 | 19 | 2 | MM15920 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 2.45e-03 | 55 | 19 | 2 | M27001 | |
| Pathway | WP_NGLYCAN_BIOSYNTHESIS | 2.63e-03 | 57 | 19 | 2 | M48051 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 4.16e-03 | 72 | 19 | 2 | M46457 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 4.98e-03 | 79 | 19 | 2 | M897 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.48e-03 | 272 | 19 | 3 | M13380 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 9.33e-03 | 330 | 19 | 3 | M18334 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 9.63e-03 | 111 | 19 | 2 | M48065 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21422162 | ||
| Pubmed | Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. | 4.18e-07 | 2 | 23 | 2 | 1608964 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 19940018 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 24303013 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 31911440 | ||
| Pubmed | The human lamin B receptor/sterol reductase multigene family. | 1.25e-06 | 3 | 23 | 2 | 9878250 | |
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 2.51e-06 | 4 | 23 | 2 | 14525949 | |
| Pubmed | Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A. | 4.18e-06 | 5 | 23 | 2 | 35610220 | |
| Pubmed | Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. | 8.77e-06 | 7 | 23 | 2 | 12627464 | |
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 6.36e-05 | 18 | 23 | 2 | 19455600 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.02e-04 | 1201 | 23 | 6 | 35696571 | |
| Pubmed | 1.05e-04 | 23 | 23 | 2 | 12955145 | ||
| Pubmed | 1.68e-04 | 29 | 23 | 2 | 34822715 | ||
| Pubmed | A compendium of expression patterns of cholesterol biosynthetic enzymes in the mouse embryo. | 2.75e-04 | 37 | 23 | 2 | 26108225 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 2.99e-04 | 499 | 23 | 4 | 22810586 | |
| Pubmed | 3.05e-04 | 200 | 23 | 3 | 18240029 | ||
| Pubmed | 4.25e-04 | 46 | 23 | 2 | 32126975 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 5.57e-04 | 1061 | 23 | 5 | 33845483 | |
| Interaction | CD79A interactions | 9.93e-06 | 262 | 23 | 5 | int:CD79A | |
| Interaction | TSPAN15 interactions | 1.28e-05 | 276 | 23 | 5 | int:TSPAN15 | |
| Interaction | YIPF3 interactions | 5.42e-05 | 186 | 23 | 4 | int:YIPF3 | |
| Interaction | ATP2A1 interactions | 9.80e-05 | 423 | 23 | 5 | int:ATP2A1 | |
| Interaction | CMTM5 interactions | 1.43e-04 | 239 | 23 | 4 | int:CMTM5 | |
| Cytoband | 11q13 | 1.60e-03 | 118 | 23 | 2 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q25 | 3.66e-03 | 180 | 23 | 2 | chr3q25 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 4.77e-07 | 2 | 13 | 2 | 448 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.71e-05 | 13 | 13 | 2 | 170 | |
| Drug | Eletriptan | 2.04e-05 | 7 | 23 | 2 | DB00216 | |
| Drug | medifoxamine | 2.72e-05 | 8 | 23 | 2 | CID000036109 | |
| Drug | DNP19 | 3.28e-05 | 62 | 23 | 3 | CID000446716 | |
| Drug | dofetilide | 3.44e-05 | 63 | 23 | 3 | CID000071329 | |
| Drug | ignosterol | 3.50e-05 | 9 | 23 | 2 | CID000090278 | |
| Drug | LY344864 | 4.37e-05 | 10 | 23 | 2 | CID005311097 | |
| Drug | 20,25-diazacholesterol | 5.34e-05 | 11 | 23 | 2 | CID000009402 | |
| Drug | alniditan | 5.34e-05 | 11 | 23 | 2 | CID000066004 | |
| Drug | NSC196867 | 7.56e-05 | 13 | 23 | 2 | CID000003982 | |
| Drug | AC1L99QI | 7.56e-05 | 13 | 23 | 2 | CID000440671 | |
| Drug | L-694,247 | 8.82e-05 | 14 | 23 | 2 | CID000132059 | |
| Drug | benzoctamine | 1.48e-04 | 18 | 23 | 2 | CID000028425 | |
| Drug | metoprolol | 1.58e-04 | 105 | 23 | 3 | CID000004171 | |
| Drug | NSC186067 | 1.65e-04 | 19 | 23 | 2 | CID000004140 | |
| Drug | GR127935 | 2.23e-04 | 22 | 23 | 2 | CID000107780 | |
| Drug | alpha-methylserotonin | 2.23e-04 | 22 | 23 | 2 | CID000115292 | |
| Drug | AC1Q70K0 | 2.66e-04 | 24 | 23 | 2 | CID000091695 | |
| Drug | pizotifen | 2.89e-04 | 25 | 23 | 2 | CID000027400 | |
| Drug | naratriptan | 2.89e-04 | 25 | 23 | 2 | CID000004440 | |
| Drug | 1-(1-naphthyl)piperazine | 3.13e-04 | 26 | 23 | 2 | CID000001342 | |
| Drug | CP-93,129 | 3.37e-04 | 27 | 23 | 2 | CID000124007 | |
| Drug | NSC169490 | 3.37e-04 | 27 | 23 | 2 | CID004210613 | |
| Drug | bufotenine | 3.37e-04 | 27 | 23 | 2 | CID000010257 | |
| Drug | NSC407316 | 3.63e-04 | 28 | 23 | 2 | CID000003067 | |
| Drug | epicholesterol | 3.71e-04 | 636 | 23 | 5 | CID000000304 | |
| Drug | tebuconazole | 4.17e-04 | 30 | 23 | 2 | CID000086102 | |
| Drug | AC1L1G8Z | 4.17e-04 | 30 | 23 | 2 | CID000003581 | |
| Drug | isopropylaniline | 4.46e-04 | 31 | 23 | 2 | CID000013032 | |
| Drug | mesulergine | 4.46e-04 | 31 | 23 | 2 | CID000068848 | |
| Drug | xanomeline | 4.46e-04 | 31 | 23 | 2 | CID000060809 | |
| Drug | mesoridazine | 5.06e-04 | 33 | 23 | 2 | CID000004078 | |
| Drug | CGS 12066B | 5.37e-04 | 34 | 23 | 2 | CID000002689 | |
| Disease | Long Qt Syndrome 2 | 1.31e-06 | 3 | 20 | 2 | C3150943 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 6.54e-06 | 6 | 20 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | Cataract | 2.87e-04 | 37 | 20 | 2 | C0086543 | |
| Disease | leptin measurement | 1.37e-03 | 81 | 20 | 2 | EFO_0005000 | |
| Disease | hearing impairment | 2.00e-03 | 98 | 20 | 2 | C1384666 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPIYYYIVVLLSYAL | 406 | O00400 | |
| LFYLIFTLYFERVLP | 321 | Q8WWZ4 | |
| PLYFLILFSIHLIYY | 986 | Q8WWZ4 | |
| YIPLALILILYYKIY | 191 | P30939 | |
| LYLLIVGILIAYYIY | 6 | P22760 | |
| FYIPLTLILILYYRI | 191 | P28566 | |
| LLYGEFLIFLLCYYI | 31 | O76090 | |
| FLIFLLCYYIIRFIY | 36 | O76090 | |
| KLLEFRYFILPYVIY | 411 | Q5I7T1 | |
| HLLPYFYIIYMAILL | 426 | Q9UBM7 | |
| LLYFFPLLFIYTFII | 41 | Q8NGY3 | |
| FLIPLAIISIYYYHI | 221 | P28336 | |
| LPYFYLLYFTALLVH | 371 | O76062 | |
| FYILWLPYIIYFLLE | 261 | Q99679 | |
| FFYILFLFIYPITLI | 26 | Q9P1Q5 | |
| IRYTLLPFLYTLFYK | 691 | P14410 | |
| KLLEFRYFILPYVIY | 411 | Q5BKT4 | |
| LILLILPYFTIFLLY | 51 | Q96MH6 | |
| LPYFTIFLLYLTIIF | 56 | Q96MH6 | |
| GLFILYLFYVVLTLY | 36 | Q6ZQQ2 | |
| FSYILYNTLLFLPYL | 256 | Q9Y5Z9 | |
| LIYPIFLLYIYFLSL | 226 | Q9BSR8 | |
| YCLFLALFLLYQYLL | 1041 | Q92508 | |
| YTGPLLIYLLFYLRI | 151 | Q5HYJ1 | |
| LIYLLFYLRIPCIYD | 156 | Q5HYJ1 | |
| VSVPCLLYVYLLYLF | 501 | O76024 | |
| GLLYYAFPYIILVLS | 211 | Q9P055 |